about
Emerging drugs for uveitisIntegration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.Anti-angiogenic treatment strategies for the therapy of endometriosis.Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis.Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features.The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis.Lymphangioleiomyomatosis and tuberous sclerosis complex.Therapies for interstitial lung disease: past, present and future.Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.An evaluation of sirolimus in renal transplantation.Everolimus and sirolimus in transplantation-related but different.Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.Nerve growth factor inhibits Na+/H+ exchange and formula absorption through parallel phosphatidylinositol 3-kinase-mTOR and ERK pathways in thick ascending limb.Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention.
P2860
Q24630848-64DFE82D-C4CA-4920-AAC3-93CA2B4FF370Q28592270-58A48346-B33C-4010-975B-25B27FE6BB6AQ34199557-17F1533E-358F-49DE-AA4D-1B980E843259Q34283036-3BE3539D-4787-45B9-A515-F46BDF9E2A32Q34675784-B5CB4BC4-D1A3-4B82-AD1E-810134C84A68Q34709640-A2B9940E-26C8-4E36-8DEA-78A55B7C5003Q34767073-8D17C8EF-4914-4D43-88C6-3D0E892A77D6Q35978150-340E0DEC-1AD6-4456-8665-1FEBBDF8207AQ37137669-3482F7E1-20C5-451C-BE81-861EBCCEC2D4Q37362642-CD631662-0E60-45BB-A955-CF690182B624Q37818197-9277BEB4-E42C-41AF-A6EE-5D83CCD212E3Q38038696-7F6BB8FC-03BE-452C-AD0D-10D7295F8B11Q38442560-0362AEDC-3FBC-4EE7-BFEA-7C7F524A61EFQ39668342-49458A94-FBB1-4976-AC9A-2FA59C715E26Q41776445-8C88FB7F-17D5-497B-B935-6E4E58959B1EQ42359937-FE406E6B-5554-4D38-AE06-9F851A405DE8
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Sirolimus--challenging current perspectives.
@ast
Sirolimus--challenging current perspectives.
@en
type
label
Sirolimus--challenging current perspectives.
@ast
Sirolimus--challenging current perspectives.
@en
prefLabel
Sirolimus--challenging current perspectives.
@ast
Sirolimus--challenging current perspectives.
@en
P1476
Sirolimus--challenging current perspectives.
@en
P2093
Hassan Izzedine
Irina Buhaescu
P304
P356
10.1097/01.FTD.0000245377.93401.39
P50
P577
2006-10-01T00:00:00Z